Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.8735 EUR -0.8% Market Closed
Market Cap: 592.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

EV/FCFF
Enterprise Value to FCFF

-1 049.2
Current
-32.7
Median
3.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-1 049.2
=
Enterprise Value
543m EUR
/
FCFF
-540k USD
All Countries
Close
Market Cap EV/FCFF
NL
Pharming Group NV
AEX:PHARM
592.7m EUR -1 049.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 369.5
US
Abbvie Inc
NYSE:ABBV
315.2B USD 23.5
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 30.2
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD -71.6
US
Epizyme Inc
F:EPE
94.1B EUR -470.6
AU
CSL Ltd
ASX:CSL
135.7B AUD 62.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 21.6
US
Seagen Inc
F:SGT
39.3B EUR -56.8
NL
argenx SE
XBRU:ARGX
36B EUR -106
 
NL
Pharming Group NV
AEX:PHARM
Average EV/FCFF: 29.8
Negative Multiple: -1 049.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 369.5
US
Abbvie Inc
NYSE:ABBV
23.5
US
Amgen Inc
NASDAQ:AMGN
30.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -71.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.6
AU
CSL Ltd
ASX:CSL
62.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -106

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More